November 9, 2009
Novocell’s top executive John West says a recent $20 million loan from a state agency comes without the strings attached by banks or other traditional lenders.
Stories this photo appears in:
Stem cell engineering company Novocell Inc. has an ambitious goal. It aims to bring the first human embryonic stem cell therapy for diabetes into the clinic in just four years.